Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01089803 · ClinicalTrials.gov registry record
Observational Study of Swallowing Function After Treatment of Advanced Laryngeal Cancer
A clinical trial of Squamous Cell Carcinoma and Laryngeal Cancer, sponsored by University of Minnesota.
- Completed
- Registry status
- 279
- Enrollment target
- 1
- Study location
NCT01089803: Completed study of Squamous Cell Carcinoma and Laryngeal Cancer, sponsored by University of Minnesota.
NCT01089803 is a study of Squamous Cell Carcinoma and Laryngeal Cancer that has completed, run by University of Minnesota. The registered enrollment target is 279 participants, above the 98-participant average among 47 other Squamous Cell Carcinoma trials with a reported enrollment target (185% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01089803, a study of Squamous Cell Carcinoma and Laryngeal Cancer, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 279 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this prospective, multi-institutional, observational cohort study is to determine if an initial surgical approach leads to better function and quality of life than primary chemoradiation in a subset of patients with advanced hypopharyngeal and laryngeal cancers.
Primary Outcome
The primary outcome will be self-reported swallowing function (M.D. Anderson Dysphagia Inventory questionnaire - MDADI) 12 months after treatment. Analysis will compare MDADI scores of patients treated initially with laryngectomy vs. those of patients treated initially with chemoradiation.
Conditions Studied
Study Locations (1)
Minnesota
- Masonic Cancer Center, University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 279 participants |
| Start Date | 2009-09 |
| Est. Completion | 2015-08 |
What the finished NCT01089803 record still lists
NCT01089803 is an observational study that tracks outcomes without assigning an intervention. The registered 279 participants enrollment target is mid-sized for trials with a published cap, above the 98-participant average among 47 other Squamous Cell Carcinoma trials with a reported enrollment target (185% higher).
The record links to 2 conditions, with Squamous Cell Carcinoma appearing as the primary indexed condition, and to 0 interventions.
NCT01089803 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT01089803 about?
NCT01089803 is a clinical study titled "Observational Study of Swallowing Function After Treatment of Advanced Laryngeal Cancer". The purpose of this prospective, multi-institutional, observational cohort study is to determine if an initial surgical approach leads to better function and quality of life than primary chemoradiation in a subset of patients with advanced hypopharyngeal and laryngeal cancers.
What is the current status of trial NCT01089803?
This trial is currently completed. The enrollment target is 279 participants. The study started on 2009-09. Estimated completion is 2015-08.
What conditions does trial NCT01089803 study?
This clinical trial studies the following conditions: Squamous Cell Carcinoma, Laryngeal Cancer.
Who is sponsoring clinical trial NCT01089803?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01089803 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Squamous Cell Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01089803's enrollment target sits among peer trials
279 4th of 47 higher than 44 of 47 other Squamous Cell Carcinoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Squamous Cell Carcinoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study of Afatinib in Advanced Cutaneous Squamous Cell Carcinoma
RECRUITING · Phase 2
-
Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck
RECRUITING · NA
-
Impact of COL7A1 Gene Therapy on SCC Recurrence in RDEB Skin
RECRUITING · Phase 2
-
Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment
RECRUITING · Phase 1
-
Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain
RECRUITING · NA
-
Toripalimab With Chemotherapy for Sinus Cancer
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04783857 · 279 participants · Phase 4
Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children
- NCT05407324 · 279 participants · Phase 2
Dazucorilant in Patients With Amyotrophic Lateral Sclerosis
- NCT06299748 · 279 participants
A Worldwide Pregnancy Safety Study to Assess Maternal, Fetal, and Infant Outcomes Following Exposure to Efgartigimod During Pregnancy and/or Breastfeeding.
- NCT06582784 · 279 participants · NA
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia